Page last updated: 2024-08-24

atorvastatin and Hematologic Diseases

atorvastatin has been researched along with Hematologic Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Collier, T; Collins, R; Dahlof, B; Gupta, A; Poulter, N; Sever, P; Thompson, D; Whitehouse, A1

Trials

1 trial(s) available for atorvastatin and Hematologic Diseases

ArticleYear
Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension p
    Lancet (London, England), 2017, Jun-24, Volume: 389, Issue:10088

    Topics: Adult; Aged; Atorvastatin; Double-Blind Method; Early Termination of Clinical Trials; Female; Hematologic Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypolipidemic Agents; Lymphatic Diseases; Male; Middle Aged; Muscular Diseases; Nocebo Effect; Risk Factors; Sleep Wake Disorders; Treatment Outcome

2017